title: Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells.
abstract: Complement-dependent activation of immune cells is regulated by cell surface membrane receptors. In this study, expression of complement receptors (CR) on human blood basophils (n = 11), tissue mast cells (lung, n = 7; skin, n = 10; uterus, n = 4; tonsil, n = 3; heart, n = 10), and on respective human cell lines (basophil line KU-812, mast cell line HMC-1) was analyzed by the use of mAbs and indirect immunofluorescence. Normal blood basophils and KU-812 cells were found to express C5aR (CD88), membrane cofactor protein (CD46), decay-accelerating factor (CD55), and membrane attack complex inhibitory factor (CD59), as well as the previously recognized CR1 (CD35), CR3 alpha (CD11b), CR4 alpha (CD11c), and CR3/4 beta (CD18). Mast cells from all organs as well as HMC-1 cells expressed CD46, CD55, and CD59, but not CD11b, CD21, or CD35. The C5aR (CD88) was detectable on skin mast cells, a subset (5 to 15%) of cardiac mast cells, and on HMC-1 cells, but not on lung, uterus, or tonsillar mast cells (< 5%). Moreover, double immunoperoxidase staining (tryptase vs C5aR/CD88) revealed in situ expression of C5aR on skin, but not lung mast cells. Recombinant human (rh) C5a, at 10(-10) to 10(-7) M, induced secretion of histamine from basophils (rhC5a, 10(-8) M: 53.4 +/- 3.1% vs control < 5%) and from skin mast cells (rhC5a, 10(-8) M: 25.8 +/- 16.1% vs control < 10% histamine release), but not from other mast cells (rhC5a or control: < 10%, p > 0.05). The rhC5a-induced secretion of histamine from basophils and skin mast cells was inhibited by S5/1, a blocking Ab against CD88 (basophils: 37.2% to 75.1%; skin mast cells: 39.2% to 83.9% inhibition, p < 0.05). Together, this study shows that a) basophils and mast cells express a different profile of complement receptors, b) C5a-dependent mediator release in skin mast cells and basophils is mediated via CD88, and c) mast cells constitute a heterogeneous lineage in terms of expression of the C5a binding site CD88.
authors.affiliation: Department of Internal Medicine, University of Vienna, Austria.
authors.forename: W
authors.initials: W
authors.lastname: Füreder
authors.forename: H
authors.initials: H
authors.lastname: Agis
authors.forename: M
authors.initials: M
authors.lastname: Willheim
authors.forename: H C
authors.initials: HC
authors.lastname: Bankl
authors.forename: U
authors.initials: U
authors.lastname: Maier
authors.forename: K
authors.initials: K
authors.lastname: Kishi
authors.forename: M R
authors.initials: MR
authors.lastname: Müller
authors.forename: K
authors.initials: K
authors.lastname: Czerwenka
authors.forename: T
authors.initials: T
authors.lastname: Radaszkiewicz
authors.forename: J H
authors.initials: JH
authors.lastname: Butterfield
authors.forename: G W
authors.initials: GW
authors.lastname: Klappacher
authors.forename: W R
authors.initials: WR
authors.lastname: Sperr
authors.forename: M
authors.initials: M
authors.lastname: Oppermann
authors.forename: K
authors.initials: K
authors.lastname: Lechner
authors.forename: P
authors.initials: P
authors.lastname: Valent
mesh_terms: D015703:Antigens, CD / Q000096:biosynthesis; D001491:Basophils / Q000276:immunology*; D002478:Cells, Cultured; D005434:Flow Cytometry; D006801:Humans; D017403:In Situ Hybridization; D008407:Mast Cells / Q000276:immunology*; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement / Q000096:biosynthesis*; D012867:Skin / Q000276:immunology*
chemical_list: D015703:Antigens, CD; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement